New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
06:51 EDTACT, CBRXColumbia Laboratories repurchases 1.4M shares of common stock from Actavis
Columbia Laboratories (CBRX) announced that the company has repurchased 1.4 million shares of its common stock, par value 1c per share, from Coventry Acquisition, a subsidiary of Actavis (ACT) at $6.08 per share, which represents a 10.75% discount to the closing price on March 6. The total purchase price was approximately $8.5M. This transaction reduces the total issued and outstanding shares of common stock by about 11.5% from approximately 12.15M to 10.75M.
News For CBRX;ACT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CBRX;ACT

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use